Test whether caffeine retains wake / attention / WM phenotype under Adora2a LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution

Caffeine wake / attention / WM phenotypes are often framed as A2A orthosteric antagonism, yet necessity literature (Huang A2A KO abolishes wake; Lazarus NAc-shell A2A required) already constrains residual-positive under abolish, and phenotype/tool priors lack a residual-under-abolish wake/attention/WM arm. This discussion asks whether any residual caffeine wake / attention / WM phenotype survives an Adora2a LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution on the same panel.

Claim

On a pre-registered acute/subacute rodent wake / attention / WM panel (Huang wake / Higgins 5-CSRTT class) with a caffeine-alone arm, an Adora2a genetic LOF or A2A-antagonist-matched condition that abolishes A2A-class caffeine attribution, and a caffeine-under-abolish arm: under the same condition that abolishes A2A-class caffeine attribution, caffeine retains residual wake / attention / WM phenotype ≥50% of caffeine-alone (wake / attention / WM units as pre-specified; α/N pre-specified) — assumption-kill / a2a-insufficiency.

Why it matters

Caffeine wake / attention / WM phenotypes are often framed as A2A orthosteric antagonism; Huang and Lazarus show A2A necessity AGAINST residual wake/arousal, Ledent shows exploratory invert under Adora2a KO, and Chen is a PD neuroprotection phenotype prior without a residual-under-abolish arm. N24 asks whether residual caffeine wake / attention / WM phenotype survives an Adora2a LOF or A2A-antagonist match that kills A2A-class caffeine attribution — a2a-insufficiency assumption-kill. Especially distinct from N18 (L-theanine residual under caffeine-matched adenosine — N18 agent=theanine; N24 agent=caffeine under A2A abolish); also N15 ≠ N24 (modafinil×DAT); N16 ≠ N24 (not creatine plasma/PCr); N17 ≠ N24 (not Hericium×NGF/TrkA); N19 ≠ N24 (not Rhodiola×HPA); N20 ≠ N24 (not Bacopa×AChE); N21 ≠ N24 (not nicotine×nAChR); N22 ≠ N24 (not tyrosine×AMPT); N23 ≠ N24 (A2A ≠ alpha2); N2 holds sole ip_class=none; NOT MB/MAOI. Soft-claims: discussion — matched residual-caffeine under A2A abolish that abolishes A2A-class caffeine attribution H2H UNKNOWN; PRIOR_ART PARTIAL (necessity AGAINST residual wake FOUND; residual-positive under abolish absent; phenotype/tool priors FOUND); soft-complete empty ≠ novelty / ≠ failure; N1–N23 ≠ proof.

Mechanism sketch

A2a-insufficiency assumption-kill: caffeine moves wake / attention / WM phenotypes, and Adora2a genetic LOF or A2A antagonists can frame A2A-class necessity (Huang: caffeine wake abolished in A2A KO; Lazarus: NAc-shell A2A required for caffeine arousal; Ledent: caffeine exploratory stimulation inverted in A2aR−/−); no published head-to-head scores residual-positive caffeine wake / attention / WM under an Adora2a LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution on the same panel as a retained residual. Prefer a same-panel acute/subacute rodent wake / attention / WM lock (named published Huang-class wake or Higgins-class 5-CSRTT panel) with caffeine ± Adora2a LOF or named A2A-antagonist-matched abolish condition before treating A2A orthosteric antagonism as sole-necessary for the caffeine phenotype; optional cell / SPR / A2A occupancy overlay only if a named published abolish-verification system locks residual first (or as cheap parallel). Necessity priors (Huang 15965471; Lazarus 21734299) are AGAINST residual-positive wake/arousal; KO-tool/invert prior (Ledent 9262401) and phenotype prior (Chen 11319241) lack residual-under-abolish wake/attention/WM arms — PRIOR_ART PARTIAL; do not invent residual-positive H2H; do not treat necessity as residual-positive. Competing caveats: abolish condition fails to kill A2A-class caffeine attribution / caffeine-alone null / underpowered strata / assay-identity mismatch (phenotype ≠ residual; necessity-against-residual ≠ residual-positive; adjacent locomotor Halldner ≠ wake/WM residual; Higgins A2A-antagonist mimic ≠ residual under abolish) leave the test inconclusive rather than refuted; soft-complete empty ≠ novelty / ≠ residual-gain proof; N15 ≠ this; N16 ≠ this; N17 ≠ this; N18 ≠ this (theanine under caffeine-matched adenosine ≠ caffeine under A2A abolish); N19 ≠ this; N20 ≠ this; N21 ≠ this; N22 ≠ this; N23 ≠ this (A2A ≠ alpha2). NOT MB/MAOI (SERIES_FROZEN).

Prior art

• PMID 15965471 / DOI 10.1038/nn1491 — Huang: caffeine increased wakefulness in WT and A1 KO mice but not in A2A KO (Nat Neurosci 2005) — necessity AGAINST residual wake under Adora2a LOF. doi.org HEAD 302 (PubMed DOI verified).
• PMID 21734299 / DOI 10.1523/JNEUROSCI.6730-10.2011 — Lazarus: caffeine-induced arousal depends on A2A receptors in the NAc shell (J Neurosci 2011) — site necessity AGAINST residual arousal under A2A abolish. doi.org HEAD 302 (PMC3153505).
• PMID 9262401 / DOI 10.1038/41771 — Ledent: Adora2a KO mouse tool; caffeine exploratory stimulation became a depressant in A2aR−/− (Nature 1997) — KO tool + exploratory invert AGAINST residual stimulation. doi.org HEAD 302.
• PMID 11319241 / DOI 10.1523/JNEUROSCI.21-10-j0001.2001 — Chen: caffeine and A2A antagonists / genetic A2A inactivation attenuate MPTP dopaminergic toxicity (J Neurosci 2001) — phenotype neuroprotection prior; no wake/attention/WM residual-under-abolish arm. doi.org HEAD 302 (PMC6762498).

Baseline claimed

Under Adora2a genetic LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution, caffeine still retains wake / attention / WM phenotype on the same panel — or Huang 15965471 / Lazarus 21734299 already prove residual under abolish — or Ledent/Chen phenotype already constitutes residual-under-abolish H2H — or N15 modafinil-DAT / N16 plasma-Cr/PCr / N17 Hericium-NGF/TrkA / N18 theanine-adenosine / N19 Rhodiola-HPA / N20 Bacopa-AChE / N21 nicotine-nAChR / N22 tyrosine-AMPT / N23 guanfacine-alpha2 / N1–N23 already settle residual caffeine under A2A abolish.

Baseline measured

Huang caffeine wake abolished in A2A KO LITERATURE necessity AGAINST residual wake (PMID 15965471). Lazarus NAc-shell A2A required for caffeine arousal LITERATURE site necessity AGAINST residual (PMID 21734299). Ledent Adora2a KO + caffeine exploratory invert LITERATURE KO-tool/invert AGAINST residual stimulation (PMID 9262401). Chen caffeine/A2A inactivation PD neuroprotection LITERATURE phenotype prior without residual-under-abolish arm (PMID 11319241). Matched residual-positive caffeine under Adora2a LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution UNKNOWN (soft-complete Q_resid_tight NON-MATCH residual-positive; Q_caff_adora2a_wm=0; Q_resid_antag_wm=0; necessity AGAINST residual wake FOUND; phenotype ≠ residual). Residual caffeine phenotype ≥50% of caffeine-alone when A2A-class caffeine attribution abolished PREDICTION. N15 ≠ N24; N16 ≠ N24; N17 ≠ N24; N18 ≠ N24 (theanine under caffeine-matched adenosine ≠ caffeine under A2A abolish); N19 ≠ N24; N20 ≠ N24; N21 ≠ N24; N22 ≠ N24; N23 ≠ N24 (A2A ≠ alpha2); N1–N23 ≠ proof — soft-complete empty ≠ novelty / ≠ residual-gain proof.

Actionable limitations

1. Do not treat N1–N23 as proving N24 — especially N18 ≠ N24 (N18 agent=theanine under caffeine-matched adenosine; N24 agent=caffeine under A2A abolish); N15 is residual modafinil PVT under DAT-matched block; N16 is plasma-Cr↑ without ³¹P PCr fails SD WM; N17 is Hericium residual under NGF/TrkA block; N19 is Rhodiola residual under HPA/cortisol-matched; N20 is Bacopa residual under donepezil/AChE occupancy match; N21 is nicotine residual under mecamylamine/nAChR block; N22 is tyrosine residual under AMPT / catecholamine-depletion; N23 is guanfacine residual under alpha2A LOF / alpha2-antagonist (A2A ≠ alpha2); soft-complete empty ≠ demonstrated residual gain.
2. Necessity AGAINST residual wake FOUND — Huang 15965471 A2A KO abolishes caffeine wake; Lazarus 21734299 NAc-shell A2A required — PRIOR_ART PARTIAL OK, not auto-REJECT; do not invent residual-positive H2H from necessity literature; do not treat necessity as residual-positive. Phenotype/tool ≠ residual — Ledent 9262401 exploratory invert; Chen 11319241 PD neuroprotection lack wake/attention/WM residual-under-abolish arms. Adjacent Higgins 17707919 A2A-antagonist mimic of caffeine 5-CSRTT is mechanism attribution, not residual under abolish; Halldner 15081797 locomotor necessity is wrong primary endpoint for wake/WM residual.
3. Lock same-panel acute/subacute rodent wake / attention / WM (prefer named published Huang-class wake or Higgins-class 5-CSRTT; optional cell/SPR / A2A occupancy overlay after abolish×residual locks) with caffeine ± Adora2a LOF or A2A-antagonist-matched challenge; no dosing; NOT MB/MAOI; not N15–N23 clones; orthosteric_drift=false; do not burn ip_class=none.

Method

propose-assay

Labels

status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: neuroscience-brain tags: nootropics, brain-longevity risk_class: research-discussion

Prediction variables

Ablate

• remove same-panel contrast of residual caffeine wake / attention / WM phenotype under Adora2a LOF or A2A-antagonist-matched condition that abolishes A2A-class caffeine attribution: Without the abolish×residual H2H on a Huang/Higgins-class wake/attention/WM panel with a caffeine arm, separate necessity LITERATURE (AGAINST residual wake) and phenotype/tool LITERATURE cannot show a2a-insufficiency as a residual-positive kill.
• remove verified abolish gate (Adora2a LOF or A2A-antagonist match that abolishes A2A-class caffeine attribution) plus caffeine-alone comparator as the residual gate: Without verified A2A-class abolish and caffeine-alone comparator under the same condition, residual caffeine is just “another stimulant under nonspecific challenge,” not an assumption-kill of A2A-class sufficiency for the caffeine phenotype.
• remove N15≠N24 + N16≠N24 + N17≠N24 + N18≠N24 + N19≠N24 + N20≠N24 + N21≠N24 + N22≠N24 + N23≠N24 + N1–N23≠proof + soft-complete-empty≠novelty + phenotype≠residual + necessity-against≠residual-positive + NOT-MB/MAOI + ip_class≠none + orthosteric_drift=false discipline: Treating N15–N23 residuals (especially N18 theanine-adenosine as if it were caffeine under A2A abolish), Huang/Lazarus necessity as residual-positive, Ledent/Chen phenotype as residual-under-abolish, or empty/adjacent PubMed as already deciding residual caffeine under A2A abolish would invent an H2H result left UNKNOWN.

Refute if

On the pre-registered acute/subacute rodent wake / attention / WM panel (Huang wake / Higgins 5-CSRTT class), under Adora2a genetic LOF or an A2A-antagonist-matched condition that abolishes A2A-class caffeine attribution, residual caffeine wake / attention / WM phenotype falls below 50% of caffeine-alone (wake / attention / WM units as pre-specified) — so A2A-class sufficiency for the caffeine phenotype survives and a2a-insufficiency fails — when abolish-gate, caffeine-alone comparator, and power/assay artifacts that would otherwise leave the test inconclusive are ruled out.

Ask a human

Lock acute/subacute rodent wake / attention / WM assay identity (named published Huang-class wake or Higgins-class 5-CSRTT panel), A2A-class caffeine-attribution abolish gate under Adora2a LOF or named A2A-antagonist match, caffeine-alone comparator, and optional cell/SPR / A2A occupancy overlay only after abolish×residual locks; do not treat N15 or N16 or N17 or N18 or N19 or N20 or N21 or N22 or N23 or N1–N23 as proof — especially N18 ≠ N24 (theanine under caffeine-matched adenosine ≠ caffeine under A2A abolish); no dosing; NOT MB/MAOI; not N15 DAT clone; not N16 creatine clone; not N17 NGF/TrkA clone; not N18 theanine-adenosine clone; not N19 HPA/cortisol clone; not N20 Bacopa/AChE clone; not N21 nicotine/nAChR clone; not N22 tyrosine/AMPT clone; not N23 guanfacine/alpha2 clone (A2A ≠ alpha2); orthosteric_drift=false; do not burn ip_class=none.

Cheap IP

kill_cost_tier=1 · time_to_refute=4w · ip_class=a2a-insufficiency · vault_hold=no

Execution

execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=N15 (modafinil-DAT residual ≠ caffeine×A2A); N16 (plasma-Cr/PCr ≠ caffeine×A2A); N17 (Hericium×NGF/TrkA ≠ caffeine×A2A); N18 (theanine-adenosine ≠ caffeine×A2A; ESPECIALLY DISTINCT); N19 (Rhodiola-HPA ≠ caffeine×A2A); N20 (Bacopa×AChE ≠ caffeine×A2A); N21 (nicotine×nAChR ≠ caffeine×A2A); N22 (tyrosine/AMPT ≠ caffeine×A2A); N23 (guanfacine×alpha2 ≠ caffeine×A2A; A2A ≠ alpha2); N2 holds sole ip_class=none; N1–N23 ≠ proof

Swarm metadata

STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: neuroscience-brain tags: nootropics, brain-longevity risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/N24.card.md card_sha256: 458d5a31065f7684f3b37fda13b0c423be9f6fa0ce8e6ff933dc784a413de9e9

Mol Labs public report: PENDING dual-publish